Table 2.
SERPINA1 SNP haplotypes in COPD patients and controls.
| Haplotypea | Patients | Controls | pb | OR | 95% CI |
| GTAGA | 0.48265 | 0.48773 | 1 | 1 | N/A |
| GCAGA | 0.21581 | 0.20572 | 0.864 | 1.04 | 0.67-1.61 |
| ATAGC | 0.18798 | 0.20385 | 0.683 | 0.91 | 0.56-1.46 |
| GTAGC | 0.08046 | 0.07999 | 0.974 | 0.99 | 0.50-1.96 |
| ATAGA | 0.01730 | 0.02270 | 0.663 | 0.77 | 0.24-2.50 |
| ATTGA | 0.00526 | 0.00000 | N/A | N/A | N/A |
| ATAAC | 0.00524 | 0.00000 | N/A | N/A | N/A |
| GCAAA | 0.00524 | 0.00000 | N/A | N/A | N/A |
| GTAAA | 0.00005 | 0.00000 | N/A | N/A | N/A |
| ACAGC | 0.00001 | 0.00000 | N/A | N/A | N/A |
aHaplotype frequency determined using expectation maximization method; bFisher's exact test.